Suchergebnisse - "Zhang, Tie"

PubPharm (30)

1

Targeting epigenetic and post-translational modifications regulating pyroptosis for the treatment of inflammatory diseases

enthalten in: Pharmacological research | 2024

von Ri-Wen | Yang, Y. | Zhang, T. | +2

2

Cellular and molecular biology of sirtuins in cardiovascular disease

enthalten in: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 2023

von Liu, Y. | Wen, R. | Liu, C. | +2

3

Roles of protein post-translational modifications in glucose and lipid metabolism : mechanisms and perspectives

enthalten in: Molecular medicine (Cambridge, Mass.) | 2023

von Yang, Y. | Wen, R. | Yang, N. | +2

4

Non-coding RNAs in metabolic reprogramming of bone and soft tissue sarcoma : Fundamental mechanism and clinical implication

enthalten in: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 2023

von Chen, H. | Hao, P. | Zhang, F. | +1

5

Ferroelectric hybrid organic-inorganic perovskites and their structural and functional diversity

enthalten in: National science review | 2023

von Zhang, T. | Xu, K. | Li, J. | +4

6

The sirtuin family in health and disease

enthalten in: Signal transduction and targeted therapy | 2022

von Wu, Q. | Zhang, T. | Chen, H. | +13

7

Mesencephalic astrocyte-derived neurotrophic factor (MANF) : Structure, functions and therapeutic potential

enthalten in: Ageing research reviews | 2022

von Liu, Y. | Huo, D. | Zeng, L. | +5

8

REGULATORY ROLE OF NONCODING RNA IN SEPSIS AND SEPSIS-ASSOCIATED ORGAN DYSFUNCTION : AN UPDATED SYSTEMATIC REVIEW

enthalten in: Shock (Augusta, Ga.) | 2022

von Zhang, T. | Yang, Y. | Liu, Y. | +2

9

Role of Posttranslational Modifications of Proteins in Cardiovascular Disease

enthalten in: Oxidative medicine and cellular longevity | 2022

von Liu, Y. | Zhang, T. | Wen, R. | +2

10

Molecular mechanisms and functions of pyroptosis in sepsis and sepsis-associated organ dysfunction

enthalten in: Frontiers in cellular and infection microbiology | 2022

von Wen, R. | Liu, Y. | Tong, X. | +2